Products & Reviews

A wide MA precision balances portfolio that features balances covering readabilities from 0.001 g down to 1 g. Large platforms, and even portable and compact models.

LA analytical balances with a readability 0.1 mg, and capacities up to 220 g, are entry-level balances that offer simple functionality without compromising on quality.

LA precision balances with a readability range between 0.001 g and 0.1 g, and capacities up to 4 kg, are entry-level balances that offer simple functionality without compromising on quality.

The CGX10 Cell Isolation System is a fully closed cell isolation system for GMP-compliant cell production and cell sorting applications. The innovative system design provides superior cell isolation along with ease of operation, with unparalleled flexibility that enables a smooth transition from process development to cell production.

MIRO CANVAS is a compact digital microfluidics platform for fully automated next generation sequencing (NGS) sample preparation. The revolutionary system drastically simplifies NGS workflows for more walk-away time and higher lab productivity, accelerating genomics discoveries.

Human iPSC-derived microglia expressing Cas9 for rapid gene knockout generation

Introducing highly-defined, consistent, and reliable human muscle cells for research, disease modeling, and high throughput screening across areas such as muscle, neuromuscular, and associated metabolic disorders. ioSkeletal Myocytes, part of the bit.bio ioCells portfolio, have been reprogrammed from human induced pluripotent stem cells (iPSCs) using bit.bio's precise reprogramming technology: opti-ox™  

A highly defined, scalable, and consistent source of human central nervous system (CNS) neurons carrying the disease-relevant 50 CAG trinucleotide repeat expansion associated with Huntington’s disease.  ioGlutamatergic Neurons HTT 50CAG/WT have been reprogrammed from human-induced pluripotent stem cells (iPSCs) using bit.bio’s precise reprogramming technology: opti-ox™ (optimized inducible overexpression).

ioMicroglia are human induced pluripotent stem cell (iPSC)-derived microglia, precision reprogrammed using opti-ox™ technology. Within 10 days post-revival, ioMicroglia are ready for experimentation, expressing (>90%) key markers, including TMEM119, P2RY12, and IBA1. ioMicroglia display key functional traits including phagocytosis and proinflammatory cytokine secretion and can be co-cultured with ioGlutamatergic Neurons™.

ioSkeletal Myocytes DMD Exon Deletion disease models are built to help improve the translatability of data generated during the discovery of new candidate drugs for Duchenne muscular dystrophy. 

QIAGEN CLC Genomics Workbench Premium now offers you a faster, more accurate, more flexible, and more affordable way to process WGS and WES files in bulk. This is made possible via QIAGEN CLC LightSpeed Module, which enables an ultra-fast, low-cost, and accurate FASTQ to VCF pipeline for variant analysis. In a recent benchmark study, CLC LightSpeed is shown to be faster, and significantly cheaper than leading alternative acce…

Sequence to construct delivered in 4 days for $89 FLAT

Highly diverse libraries with 95% guaranteed coverage and industry-leading acceptance rate, delivered in as little as 2 weeks.

Detect antimicrobial resistance with proven expertise

Unmatched throughput. Simple to use. Peace of mind. 

REMISOL Advance is a leading middleware solution for today’s clinical laboratories, bridging laboratory information systems (LIS) and instrumentation. It helps drive improved operational efficiency within and across the laboratory network through process automation and standardization.

Helping fertility patients plan for the family they desire

Confidently report accurate results with the first true high-sensitivity troponin I assay cleared by the FDA

Timely, accurate Procalcitonin test results. Now CLIA categorized.

Remote monitoring for improving laboratory productivity

One less thing to worry about

One insight can make a big impact

More meaningful work starts with better workflows

Making a difference in reproductive health

An FDA approved, CE marked blood test to be used as an aid in distinguishing prostate cancer from benign prostatic conditions